About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? [email protected]

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Clinical Trials in Philadelphia | 17,547 Studies Near You

Clinical TrialsPhiladelphia

Clinical Trials in Philadelphia

Discover 17,547 clinical trials near Philadelphia, Pennsylvania. Find research studies in your area.

Browse by condition:

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma Pancreatic Cancer

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 5961-5980 of 17,547 trials

TerminatedStudy of EG-1962 Compared to Standard of Care Oral Nimodipine in Adults With Aneurysmal Subarachnoid HemorrhageThis study compares EG-1962 to enteral nimodipine in the treatment of aneurysmal subarachnoid hemorrhage.NCT02790632·Birmingham, Alabama and 78 others

Find Trials by Condition in Philadelphia

Breast Cancerin Philadelphia Lung Cancerin Philadelphia Prostate Cancerin Philadelphia Colorectal Cancerin Philadelphia Melanomain Philadelphia Leukemiain Philadelphia Lymphomain Philadelphia Pancreatic Cancerin Philadelphia Ovarian Cancerin Philadelphia Brain Cancerin Philadelphia

Data from ClinicalTrials.govTerms

Active not recruitingA Study of Health Care Use and Costs in Participants With Early Stage Alzheimer's Disease (AD)The purpose of this study is to learn about health care use, costs, and clinical outcomes over time for amyloid positive participants with early stages of AD in the United States.NCT02951598·Anaheim, California and 76 others

CompletedTreatment of Breakthrough Pain in Opioid Tolerant Cancer PatientsThe purpose of this study is to evaluate the safety and tolerability of OraVescent fentanyl when used long-term to relieve breakthrough pain in opioid tolerant cancer patients.NCT00105287·Cullman, Alabama and 25 others

TerminatedA Study to Evaluate the Safety and Preliminary Efficacy of ATA3219 in Participants With Relapsed/Refractory B-cell Non-Hodgkin LymphomaThe purpose of this study is to evaluate the safety and preliminary efficacy of ATA3219 in participants with relapsed/refractory (R/R) B-cell non-Hodgkin Lymphoma (NHL).NCT06256484·Orlando, Florida and 5 others

CompletedQuality of Life in Female Breast Cancer Survivors and Their Spouse, Partner, or AcquaintanceRATIONALE: Studying quality of life in breast cancer survivors may help determine the long-term effects of breast cancer and may help improve the quality of life for future breast…NCT00309933·Monterey, California and 103 others

CompletedSpy II Clinical RegistryA prospective, multi-center registry for subjects undergoing Endoscopic retrograde Cholangiopancreatography (ERCP) and cholangioscopy for known or suspected pancreaticobiliary…NCT00751998·San Francisco, California and 14 others

WithdrawnVitamin E Efficacy in HI/HACongenital hyperinsulinism (HI) is a rare disorder of pancreatic beta cell insulin secretion that causes persistent and severe hypoglycemia starting at birth.NCT04984798·Philadelphia, Pennsylvania

CompletedCR845-CLIN3105: A Study to Evaluate the Safety and Effectiveness of CR845 in Hemodialysis Patients With Moderate-to-Severe PruritusThis is a multicenter, open-label study to evaluate the safety and effectiveness of intravenous (IV) CR845 at a dose of 0.5 mcg/kg administered after each dialysis session.NCT03998163·Escondido, California and 46 others

UnknownHEAD Injury Serum Markers and Multi-modalities for Assessing Response to TraumaThe goal of HeadSMART II (HEAD injury Serum markers and Multi-modalities for Assessing Response to Trauma II) is to develop an In-Vitro Diagnostic, the BRAINBox TBI test, to aid…NCT04423198·Kansas City, Kansas and 10 others

Active not recruitingA Study of AT-02 in Subjects With Systemic Amyloidosis.This is a Phase 2 open-label extension study to evaluate the long-term safety, tolerability, and clinical activity of AT-02.NCT05951049·Kansas City, Kansas and 3 others

Active not recruitingResponse-Based Chemotherapy in Treating Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndrome in Younger Patients With Down SyndromeThis phase III trial studies response-based chemotherapy in treating newly diagnosed acute myeloid leukemia or myelodysplastic syndrome in younger patients with Down syndrome.NCT02521493·Birmingham, Alabama and 190 others

CompletedSirolimus and Azacitidine in Treating Patients With High Risk Myelodysplastic Syndrome or Acute Myeloid Leukemia That is Recurrent or Not Eligible for Intensive ChemotherapyThis phase II trial studies how well sirolimus and azacitidine works in treating patients with high-risk myelodysplastic syndrome or recurrent acute myeloid leukemia.NCT01869114·Sewell, New Jersey and 4 others

Active not recruitingEnasidenib for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia Patients With an IDH2 MutationThis phase II trial studies the side effects of enasidenib and sees how well it works in treating pediatric patients with acute myeloid leukemia that has come back after treatment…NCT04203316·Birmingham, Alabama and 27 others

CompletedABSORB III Randomized Controlled Trial (RCT)The ABSORB III RCT is a prospective randomized, single-blind, multi-center trial.NCT01751906·Birmingham, Alabama and 191 others

CompletedFlorbetapir F 18 PET Imaging of Beta-amyloid in Parkinson's Disease PatientsThe primary aim of this study is to compare regional amyloid burden in Parkinson's disease (PD) to normal control subjects.NCT00857532·Philadelphia, Pennsylvania

Active not recruitingCD40 Agonist and PD-1 Inhibitor in HNSCCProspective, open-label, phase 1 study of CD40 agonist (LVGN7409) and PD-1 inhibition (LVGN3616 or nivolumab) in patients with resectable Human Papillomavirus (HPV)-negative…NCT06159621·Philadelphia, Pennsylvania

CompletedTherapeutic Use of Tadekinig Alfa in NLRC4 Mutation and XIAP Deficiency As Open Label ExtensionThis is an open-label extension study for patients previously enrolled in the AB2 Bio Ltd. ongoing Phase III clinical trial NLRC4/XIAP.2016.001 (IND N° 127953).NCT03512314·La Jolla, California and 10 others

CompletedSafety and Effectiveness of AZLI (an Inhaled Antibiotic) in Adults With Non-Cystic Fibrosis BronchiectasisThe AIR-BX2 study enrolled people with non-cystic fibrosis (non-CF) bronchiectasis and gram-negative airway infection.NCT01314716·Florence, Alabama and 84 others

CompletedAssessment of Prospective CYP2C19 Genotype Guided Dosing of Anti-Platelet Therapy in Percutaneous Coronary InterventionThis is a randomized, prospective, open label study to determine the cost-effectiveness of genotype-guided antiplatelet therapy.NCT02508116·Philadelphia, Pennsylvania and 1 other

CompletedA Clinical Study Examining the Safety and Effectiveness of a New Medication (Keppra®) for the Prevention of Migraine HeadachesThe study drug levetiracetam is FDA approved as an add-on medication in the treatment of partial onset seizures in adults with epilepsy. The trade name is Keppra®.NCT00203216·Philadelphia, Pennsylvania

PreviousPage 299 of 878Next

Diabetes

in Philadelphia

Heart Diseasein Philadelphia